Targeted radiotherapy for neuroblastoma.
作者信息
Meller S
机构信息
Children's Department, Royal Marsden NHS Trust, Surrey.
出版信息
Arch Dis Child. 1997 Nov;77(5):389-91. doi: 10.1136/adc.77.5.389.
Abstract
摘要
相似文献
1
Targeted radiotherapy for neuroblastoma.
Arch Dis Child. 1997 Nov;77(5):389-91. doi: 10.1136/adc.77.5.389.
2
The role of 131I-MIBG in high-risk neuroblastoma treatment.
J Pediatr Oncol Nurs. 2009 Jul-Aug;26(4):208-16. doi: 10.1177/1043454209340316.
3
Letter to the editor.
Radiat Prot Dosimetry. 2015 Mar;163(4):533-4. doi: 10.1093/rpd/ncu278. Epub 2014 Sep 16.
4
Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
Pediatr Blood Cancer. 2011 Jul 1;56(7):1032-40. doi: 10.1002/pbc.22986. Epub 2011 Feb 22.
5
Iodine-131-metaiodobenzylguanidine therapy with reduced-intensity allogeneic stem cell transplantation in recurrent neuroblastoma.
Pediatr Blood Cancer. 2008 Mar;50(3):676-8. doi: 10.1002/pbc.21126.
6
A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma.
Eur J Cancer. 2014 Mar;50(4):801-15. doi: 10.1016/j.ejca.2013.11.016. Epub 2013 Dec 12.
7
Hypothyroidism after treatment of metastatic neuroblastoma.
Pediatr Blood Cancer. 2010 Oct;55(4):768. doi: 10.1002/pbc.22593.
8
Neuroblastoma maturation by [(131)I] metaiodobenzylguanidine in chemoresistant neuroblastoma.
Med Pediatr Oncol. 1999 Oct;33(4):418-9. doi: 10.1002/(sici)1096-911x(199910)33:4<418::aid-mpo18>3.0.co;2-9.
9
Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma.
Q J Nucl Med Mol Imaging. 2013 Mar;57(1):66-78.
10
Iodine-131-labeled meta-iodobenzylguanidine therapy of children with neuroblastoma: program planning and initial experience.
Semin Nucl Med. 2011 Sep;41(5):354-63. doi: 10.1053/j.semnuclmed.2011.06.001.
引用本文的文献
1
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
Eur J Nucl Med Mol Imaging. 2007 May;34(5):772-786. doi: 10.1007/s00259-006-0338-5.
本文引用的文献
1
The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro.
Br J Cancer. 1997;75(4):470-6. doi: 10.1038/bjc.1997.82.
2
Targeted therapy using alpha emitters.
Phys Med Biol. 1996 Oct;41(10):1915-31. doi: 10.1088/0031-9155/41/10/005.
3
Primary hypothyroidism as a consequence of 131-I-metaiodobenzylguanidine treatment for children with neuroblastoma.
Cancer. 1995 Nov 1;76(9):1662-4. doi: 10.1002/1097-0142(19951101)76:9<1662::aid-cncr2820760924>3.0.co;2-v.
4
5
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation.
J Clin Oncol. 1993 Dec;11(12):2330-41. doi: 10.1200/JCO.1993.11.12.2330.
6
Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.
Eur J Nucl Med. 1994 Jun;21(6):545-59. doi: 10.1007/BF00173043.
7
Synthesis of carrier-free 131I-meta-iodobenzyl-guanidine by novel routes to enhance therapeutic efficiency in neuroblastoma.
Prog Clin Biol Res. 1994;385:347-53.
8
Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
Cancer Res. 1994 Oct 15;54(20):5414-9.
9
Multi-modality megatherapy with [131I]meta-iodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of a new strategy for advanced neuroblastoma.
Eur J Cancer. 1995;31A(2):252-6. doi: 10.1016/0959-8049(94)e0036-4.
10
A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
Eur J Cancer. 1995;31A(4):606-11. doi: 10.1016/0959-8049(95)00048-n.
Zotero 插件